Innospec (IOSP) Earning Somewhat Favorable Press Coverage, Analysis Shows

Media headlines about Innospec (NASDAQ:IOSP) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Innospec earned a news impact score of 0.21 on Accern’s scale. Accern also gave news headlines about the specialty chemicals company an impact score of 45.8343942914007 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Innospec (NASDAQ:IOSP) traded down $1.00 on Wednesday, hitting $71.80. 56,807 shares of the stock traded hands, compared to its average volume of 75,367. The company has a current ratio of 2.24, a quick ratio of 1.35 and a debt-to-equity ratio of 0.30. Innospec has a fifty-two week low of $54.10 and a fifty-two week high of $74.75. The company has a market cap of $1,765.66, a price-to-earnings ratio of 19.89 and a beta of 1.21.

Innospec (NASDAQ:IOSP) last posted its earnings results on Tuesday, November 7th. The specialty chemicals company reported $1.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.85 by $0.15. Innospec had a net margin of 7.45% and a return on equity of 15.05%. The business had revenue of $332.40 million for the quarter, compared to analyst estimates of $309.40 million. During the same quarter in the prior year, the firm earned $0.78 EPS. The firm’s quarterly revenue was up 61.8% compared to the same quarter last year. sell-side analysts predict that Innospec will post 4.3 EPS for the current fiscal year.

A number of equities analysts recently issued reports on the stock. BidaskClub lowered shares of Innospec from a “hold” rating to a “sell” rating in a research report on Thursday, January 25th. Zacks Investment Research lowered shares of Innospec from a “buy” rating to a “hold” rating in a research report on Wednesday, January 10th. Johnson Rice raised shares of Innospec from a “hold” rating to an “accumulate” rating in a report on Tuesday, November 14th. Monness Crespi & Hardt lowered shares of Innospec from a “buy” rating to a “neutral” rating in a report on Thursday, November 9th. Finally, KeyCorp reissued an “overweight” rating on shares of Innospec in a report on Thursday, November 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $70.50.

In related news, insider Philip Curran sold 375 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $71.56, for a total transaction of $26,835.00. Following the transaction, the insider now owns 2,968 shares in the company, valued at approximately $212,390.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Ian Cleminson sold 5,000 shares of the company’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $71.67, for a total transaction of $358,350.00. Following the transaction, the chief financial officer now owns 22,997 shares in the company, valued at approximately $1,648,194.99. The disclosure for this sale can be found here. In the last ninety days, insiders sold 24,366 shares of company stock worth $1,743,891. 2.02% of the stock is owned by insiders.

ILLEGAL ACTIVITY NOTICE: This report was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://www.dispatchtribunal.com/2018/01/31/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-innospec-iosp-share-price.html.

Innospec Company Profile

Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply